* Healthequity Inc HQY.OQ HQY.O is expected to show a
rise in
quarterly revenue when it reports results on March 21.
* The Draper Utah-based company is expected to report a
13.5% increase in revenue to $230.725 million from $203.3
million a year ago, according to the mean estimate from 13
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Healthequity Inc is
for
earnings of 35 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for
Healthequity Inc
is $84, above its last closing price of $59.00.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Oct. 31 2022 0.35 0.35 0.38 Beat 9.7
Jul. 31 2022 0.33 0.33 0.33 Met 0
Apr. 30 2022 0.25 0.26 0.27 Beat 3.8
Jan. 31 2022 0.21 0.22 0.20 Missed -7.8
Oct. 0.35 0.35 0.35 Met 0.8
31 2021
Jul. 31 2021 0.36 0.36 0.40 Beat 10.9
Apr. 30 2021 0.31 0.32 0.38 Beat 18.1
Jan. 31 2021 0.42 0.40 0.42 Beat 6.2
This summary was machine generated March 17 at 20:04 GMT. All
figures in US dollars unless otherwise stated